sales@intentmarketresearch.com

  +1 463-583-2713

Molecular Diagnostics Market By Test Type (Lab, PoC), By Product & Service (Reagents & Kits, Instruments, Services & Software), By Sample Type (Urine, Blood, Serum & Plasma), By Technology (Polymerase Chain Reaction, DNA Sequencing & Next-Generation Sequencing, In-situ Hybridization, Isothermal Nucleic Acid Amplification Technology, DNA Microarray), By Application (Infectious Diseases, Oncology Testing, Genetic Testing, COVID-19), By End Use (Diagnostic Laboratories Hospitals & Clinics), and by Region; Global Insights & Forecasts (2024 - 2030)

Published: October, 2024  
|   Report ID: LI3450  
|   Life Sciences & Healthcare

As per Intent Market Research, the Molecular Diagnostics Market was valued at USD 15.8 billion in 2023 and will surpass USD 32.6 billion by 2030; growing at a CAGR of 10.9% during 2024 - 2030.

The report focuses on estimating the current market potential in terms of the total addressable market for all the segments, sub-segments, and regions. In the process, all the high-growth and upcoming technologies were identified and analyzed to measure their impact on the current and future market. The report also identifies the key stakeholders, their business gaps, and their purchasing behavior. This information is essential for developing effective marketing strategies and creating products or services that meet the needs of the target market. The report also covers a detailed analysis of the competitive landscape which includes major players, their recent developments, growth strategies, product benchmarking, and manufacturing operations among others. Also, brief insights on start-up ecosystem and emerging companies are also included as part of this report.

Report Objectives:

The report will help you answer some of the most critical questions in the Molecular Diagnostics Market. A few of them are as follows:

  1. What are the key drivers, restraints, opportunities, and challenges influencing the market growth?
  2. What are the prevailing technology trends in the molecular diagnostics market?
  3. What is the size of the molecular diagnostics market based on segments, sub-segments, and regions?
  4. What is the size of different market segments across key regions: North America, Europe, Asia Pacific, Latin America, Middle East & Africa?
  5. What are the market opportunities for stakeholders after analyzing key market trends?
  6. Who are the leading market players and what are their market share and core competencies?
  7. What is the degree of competition in the market and what are the key growth strategies adopted by leading players?
  8. What is the competitive landscape of the market, including market share analysis, revenue analysis, and a ranking of key players?

Report Scope:

Report Features

Description

Market Size (2023-e)

USD 15.8 billion

Forecasted Value (2030)

USD 32.6 billion

CAGR (2024-2030)

10.9%

Base Year for Estimation

2023

Historic Year

2022

Forecast Period

2024-2030

Report Coverage

Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments

Segments Covered

Molecular Diagnostics Market By Test Type (Lab, PoC), By Product & Service (Reagents & Kits, Instruments, Services & Software), By Sample Type (Urine, Blood, Serum & Plasma), By Technology (Polymerase Chain Reaction, DNA Sequencing & Next-Generation Sequencing, In-situ Hybridization, Isothermal Nucleic Acid Amplification Technology, DNA Microarray), By Application (Infectious Diseases, Oncology Testing, Genetic Testing, COVID-19), By End Use (Diagnostic Laboratories Hospitals & Clinics)

Regional Analysis

North America (US, Canada, Mexico), Europe (Germany, France, UK, Spain, Italy & Rest of Europe), Asia Pacific (China, Japan, South Korea, India, and rest of Asia Pacific), Latin America (Brazil, Argentina, & Rest of Latin America), Middle East & Africa (Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA)

Customization Scope

Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements

1.Introduction

1.1.Market Definition

1.2.Scope of the Study

1.3.Research Assumptions

1.4.Study Limitations

2.Research Methodology

2.1.Research Approach

2.1.1.Top-Down Method

2.1.2.Bottom-Up Method

2.1.3.Factor Impact Analysis

2.2.Insights & Data Collection Process

2.2.1.Secondary Research

2.2.2.Primary Research

2.3.Data Mining Process

2.3.1.Data Analysis

2.3.2.Data Validation and Revalidation

2.3.3.Data Triangulation

3.Executive Summary

3.1.Major Markets & Segments

3.2.Highest Growing Regions and Respective Countries

3.3.Impact of Growth Drivers & Inhibitors

3.4.Regulatory Overview by Country 

4.Molecular Diagnostics Market, by Product & Service (Market Size & Forecast: USD Billion, 2024 – 2030)

4.1.Instruments

4.2.Reagents & Kits

4.3.Services & Software

5.Molecular Diagnostics Market, by Test Type (Market Size & Forecast: USD Billion, 2024 – 2030)

5.1.Lab Tests

5.2.PoC Tests

6.Molecular Diagnostics Market, by Sample Type (Market Size & Forecast: USD Billion, 2024 – 2030)

6.1.Blood, Serum & Plasma

6.2.Urine

6.3.Others

7.Molecular Diagnostics Market, by Technology (Market Size & Forecast: USD Billion, 2024 – 2030)

7.1.Polymerase Chain Reaction

7.2.DNA Sequencing & Next-generation Sequencing

7.3.Insitu Hybridization

7.4.Isothermal Nucleic Acid Amplification Technology

7.5.DNA Microarray

7.6.Others

8.Molecular Diagnostics Market, by Application (Market Size & Forecast: USD Billion, 2024 – 2030)

8.1.Infectious Disease Diagnostics

8.1.1.Tuberculosis

8.1.2.HIV

8.1.3.CT/NG

8.1.4.HPV

8.1.5.HAI

8.1.6.Hepatitis

8.1.7.Influenza

8.1.8.Other Infectious Diseases

8.2.Oncology Testing

8.2.1.Prostate Cancer

8.2.2.Colorectal Cancer

8.2.3.Lung Cancer

8.2.4.Breast Cancer

8.2.5.Other Cancers

8.3.Genetic Testing

8.4.COVID-19

         9.Molecular Diagnostics Market, by End Use (Market Size & Forecast: USD Billion, 2024 – 2030)

9.1.Diagnostic Laboratories

9.2.Hospitals & Clinics

9.3.Others

10.Regional Analysis (Market Size & Forecast: USD Billion, 2024 – 2030)

10.1.Regional Overview

10.2.North America

10.2.1.Regional Trends & Growth Drivers

10.2.2.Barriers & Challenges

10.2.3.Opportunities

10.2.4.Factor Impact Analysis

10.2.5.Technology Trends

10.2.6.North America Molecular Diagnostics Market, by Product & Service

10.2.7.North America Molecular Diagnostics Market, by Test Type

10.2.8.North America Molecular Diagnostics Market, by Sample Type

10.2.9.North America Molecular Diagnostics Market, by Technology

10.2.10.North America Molecular Diagnostics Market, by Application

10.2.11.North America Molecular Diagnostics Market, by End Use

*Similar segmentation will be provided at each regional level

10.3.By Country

10.3.1.US

10.3.1.1.US Molecular Diagnostics Market, by Product & Service

10.3.1.2.US Molecular Diagnostics Market, by Test Type

10.3.1.3.US Molecular Diagnostics Market, by Sample Type

10.3.1.4.US Molecular Diagnostics Market, by Technology

10.3.1.5.US Molecular Diagnostics Market, by Application

10.3.1.6.US Molecular Diagnostics Market, by End Use

10.3.2.Canada

10.3.3.Mexico

          *Similar segmentation will be provided at each country level

8.4.Europe

8.5.APAC

8.6.Latin America

8.7.Middle East & Africa

9.Competitive Landscape

9.1.Overview of the Key Players

9.2.Competitive Ecosystem

9.2.1.Platform Manufacturers

9.2.2.Subsystem Manufacturers

9.2.3.Service Providers

9.2.4.Software Providers

9.3.Company Share Analysis

9.4.Company Benchmarking Matrix

9.4.1.Strategic Overview

9.4.2.Product Innovations

9.5.Start-up Ecosystem

9.6.Strategic Competitive Insights/ Customer Imperatives

9.7.ESG Matrix/ Sustainability Matrix

9.8.Manufacturing Network

9.9.1.Locations

9.9.2.Supply Chain and Logistics

9.9.3.Product Flexibility/Customization

9.9.4.Digital Transformation and Connectivity

9.9.5.Environmental and Regulatory Compliance

9.9.Technology Readiness Level Matrix

9.10.Technology Maturity Curve

9.11.Buying Criteria

10.Company Profiles

10.1.Abbott

10.1.1.Company Overview

10.1.2.Company Financials

10.1.3.Product/Service Portfolio

10.1.4.Recent Developments

10.1.5.IMR Analysis

*Similar information will be provided for other companies 

10.2.Roche Diagnostics

10.3.Hologic

10.4.Illumina

10.5.Danaher

10.6.Thermo Fisher Scientific

10.7.bioMérieux

10.8.Becton, Dickinson, and Company

10.9.Siemens Healthineers

10.10.Qiagen

11.Appendix

Let us connect with you TOC

I have read the Terms & Conditions and Privacy Policy I agree to its terms

A comprehensive market research approach was employed to gather and analyze data on the Molecular Diagnostics Market. In the process, the analysis was also done to estimate the parent market and relevant adjacencies to measure the impact of them on the molecular diagnostics market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.

Research Approach - Molecular Diagnostics Market

Secondary Research

Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.

Primary Research

Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the molecular diagnostics ecosystem. The primary research objectives included:

  • Validating findings and assumptions derived from secondary research
  • Gathering qualitative and quantitative data on market trends, drivers, and challenges
  • Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
  • Assessing the supply-side landscape, including technological advancements and recent developments

Market Size Estimation

A combination of top-down and bottom-up approaches was utilized to estimate the overall size of the molecular diagnostics market. These methods were also employed to estimate the size of various subsegments within the market. The market size estimation methodology encompassed the following steps:

  1. Identification of key industry players and relevant revenues through extensive secondary research
  2. Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
  3. Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources

Bottom Up and Top Down - Molecular Diagnostics Market

Data Triangulation

To ensure the accuracy and reliability of the market size estimates, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size estimates.

Let us connect with you


I have read the Terms & Conditions and Privacy Policy I agree to its terms
Available Formats
REPORT BUYING OPTIONS


Buy Now